| C3a and C5a stimulate chemotaxis of human mast cells K Hartmann, BM Henz, S Krüger-Krasagakes, J Köhl, R Burger, S Guhl, ... Blood, The Journal of the American Society of Hematology 89 (8), 2863-2870, 1997 | 427 | 1997 |
| Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance … A Grutzkau, S Kruger-Krasagakes, H Baumeister, C Schwarz, H Kogel, ... Molecular biology of the cell 9 (4), 875-884, 1998 | 425 | 1998 |
| Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the … C Garbe, S Krüger, CE Orfanos, P Büttner, J Weiß, HP Soyer, U Stocker, ... Journal of investigative dermatology 102 (5), 695-699, 1994 | 401 | 1994 |
| Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: Multicenter case-control study of the Central … C Garbe, S Krüger, CE Orfanos, P Büttner, J Weiß, HP Soyer, U Stocker, ... Journal of investigative dermatology 102 (5), 700-705, 1994 | 225 | 1994 |
| Expression of interleukin 10 in human melanoma S Krüger-Krasagakes, K Krasagakis, C Garbe, E Schmitt, C Hüls, ... British journal of cancer 70 (6), 1182-1185, 1994 | 197 | 1994 |
| Elevated plasma levels of transforming growth factor (TGF)-β1 and TGF-β2 in patients with disseminated malignant melanoma K Krasagakis, D Thölke, B Farthmann, J Eberle, U Mansmann, ... British journal of cancer 77 (9), 1492-1494, 1998 | 188 | 1998 |
| Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration G Richter, S Krüger-Krasagakes, G Hein, C Hüls, E Schmitt, ... Cancer research 53 (18), 4134-4137, 1993 | 185 | 1993 |
| Human skin mast cells express H2 and H4, but not H3 receptors U Lippert, M Artuc, A Grützkau, M Babina, S Guhl, I Haase, V Blaschke, ... Journal of investigative dermatology 123 (1), 116-123, 2004 | 180 | 2004 |
| Comparative cytokine gene expression: regulation and release by human mast cells MÖLLER, HENZ, GRÜTZKAU, LIPPERT, ARAGANE, SCHWARZ Immunology 93 (2), 289-295, 1998 | 168 | 1998 |
| Expression of MUC2‐mucin in colorectal adenomas and carcinomas of different histological types M Blank, E Klussmann, S Krüger‐Krasagakes, A Schmitt‐Gräff, M Stolte, ... International journal of cancer 59 (3), 301-306, 1994 | 148 | 1994 |
| Pharmacological modulation of IL‐6 and IL‐8 secretion by the H1‐antagonist decarboethoxy‐loratadine and dexamethasone by human mast and basophilic cell lines U Lippert, S Krüger‐Krasagakes, A Möller, U Kiessling, BM Czarnetzki Experimental Dermatology 4 (4), 272-276, 1995 | 140 | 1995 |
| Markers and relative risk in a German population for developing malignant melanoma C Garbe, S Krüger, R Stadler, I Guggenmoos‐Holzmann, CE Orfanos International journal of dermatology 28 (8), 517-523, 1989 | 133 | 1989 |
| Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma: results of a case control study in melanoma … S Krüger, C Garbe, P Büttner, R Stadler, I Guggenmoos-Holzmann, ... Journal of the American Academy of Dermatology 26 (6), 920-926, 1992 | 128 | 1992 |
| Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells U Lippert, M Artuc, A Grutzkau, A Möller, A Kenderessy-Szabo, ... The Journal of immunology 161 (5), 2600-2608, 1998 | 119 | 1998 |
| Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo MB ABDEL‐NASER, S Krüger‐Krasagakes, K Krasagakis, H Gollnick, ... Pigment Cell Research 7 (1), 1-8, 1994 | 112 | 1994 |
| Production of interleukin-6 by human mast cells and basophilic cells S Krüger-Krasagakes, A Möller, G Kolde, U Lippert, M Weber, BM Henz Journal of investigative dermatology 106 (1), 75-79, 1996 | 106 | 1996 |
| Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype C Garbe, K Krasagakis, CC Zouboulis, K Schröder, S Krüger, R Stadler, ... Journal of investigative dermatology 95 (6), S231-S237, 1990 | 89 | 1990 |
| Overall and site‐specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case‐control study of the German Central Malignant … E Rieger, HP Soyer, C Garbe, P Büttner, R Kofler, J Weiss, U Stocker, ... International journal of cancer 62 (4), 393-397, 1995 | 83 | 1995 |
| Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis. Z Qin, S Krüger-Krasagakes, U Kunzendorf, H Hock, T Diamantstein, ... The Journal of experimental medicine 178 (1), 355-360, 1993 | 83 | 1993 |
| Report: Analysis of epidemiology, clinical features and management of erysipelas K Krasagakis, A Valachis, P Maniatakis, S Krüger‐Krasagakis, G Samonis, ... International journal of dermatology 49 (9), 1012-1017, 2010 | 75 | 2010 |
